Approval · Notice of Compliance 4157 · 1997
TOPAMAX: Notice of Compliance 4157
Issued March 6, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4157
- Date
- March 6, 1997
- Company
- Janssen-Ortho Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Anti-epileptic
Products in this notice
Medicinal ingredients
- TOPIRAMATE 25 MG per TAB
- TOPIRAMATE 100 MG per TAB
- TOPIRAMATE 200 MG per TAB